Tumor necrosis factor-alpha (TNF-α) is a therapeutic target for impaired cutaneous wound healing

Wound Repair and Regeneration

Volumn 20, Issue 1, 2012, Pages 38-49

  Ashcroft, Gillian S ^a,b   Jeong, Moon Jin ^a,d   Ashworth, Jason J ^b   Hardman, Matthew ^b   Jin, Wenwen ^a   Moutsopoulos, Niki ^a   Wild, Teresa ^a   McCartney Francis, Nancy ^a   Sim, Davis ^a   McGrady, George ^a   Song, Xiao Yu ^c   Wahl, Sharon M ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c Research and Development   (United States)

^d Chosun University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; LEUKOCYTE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SKIN INJURY; WOUND HEALING IMPAIRMENT;

ADMINISTRATION, CUTANEOUS; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, NEUTRALIZING; BIOPSY; CELLS, CULTURED; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MICE; MIDDLE AGED; NF-KAPPA B P50 SUBUNIT; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; TUMOR NECROSIS FACTOR-ALPHA; VARICOSE ULCER; WOUND HEALING;

EID: 84856318814     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2011.00748.x     Document Type: Article

References (40)

1. Ashcroft GS, Greenwell-Wild T, Horan MA, Wahl SM, Ferguson MW,. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol 1999; 155: 1137-1146. (Pubitemid 29488922)
2. Schafer M, Werner S,. Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol 2008; 9: 628-638.
3. Song X, Zeng L, Jin W, Thompson J, Mizel DE, Lei K, Billinghurst RC, Poole AR, Wahl SM,. Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis. J Exp Med 1999; 190: 535-542. (Pubitemid 29395381)
4. Feldmann M, Williams RO, Paleolog E,. What have we learnt from targeted anti-TNF therapy? Ann Rheum Dis 2010; 69 (Suppl. 1): i97-99.
5. Chan JM, Villarreal G, Jin WW, Stepan T, Burstein H, Wahl SM,. Intraarticular gene transfer of TNFR:Fc suppresses experimental arthritis with reduced systemic distribution of the gene product. Mol Ther 2002; 6: 727-736. (Pubitemid 36054306)
6. Bruunsgaard H, Pedersen BK,. Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am 2003; 23: 15-39. (Pubitemid 36268302)
7. Bruunsgaard H,. Effects of tumor necrosis factor-alpha and interleukin-6 in elderly populations. Eur Cytokine Netw 2002; 13: 389-391. (Pubitemid 36174091)
8. Mendez MV, Raffetto JD, Phillips T, Menzoian JO, Park HY,. The proliferative capacity of neonatal skin fibroblasts is reduced after exposure to venous ulcer wound fluid: a potential mechanism for senescence in venous ulcers. J Vasc Surg 1999; 30: 734-743. (Pubitemid 29487567)
9. Huttunen M, Aalto ML, Harvima RJ, Horsmanheimo M, Harvima IT,. Alterations in mast cells showing tryptase and chymase activity in epithelializating and chronic wounds. Exp Dermatol 2000; 9: 258-265. (Pubitemid 30458508)
10. Ashcroft GS, Lei K, Jin W, Longenecker G, Kulkarni AB, Greenwell-Wild T, Hale-Donze H, McGrady G, Song XY, Wahl SM,. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat Med 2000; 6: 1147-1153.
11. Angelov N, Moutsopoulos N, Jeong MJ, Nares S, Ashcroft G, Wahl SM,. Aberrant mucosal wound repair in the absence of secretory leukocyte protease inhibitor. Thromb Haemost 2004; 92: 288-297. (Pubitemid 39172309)
12. Zhu J, Nathan C, Jin W, Sim D, Ashcroft GS, Wahl SM, Lacomis L, Erdjument-Bromage H, Tempst P, Wright CD, Ding A,. Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 2002; 111: 867-878. (Pubitemid 36106407)
13. Franzke CW, Baici A, Bartels J, Christophers E, Wiedow O,. Antileukoprotease inhibits stratum corneum chymotryptic enzyme. Evidence for a regulative function in desquamation. J Biol Chem 1996; 271: 21886-21890. (Pubitemid 26303810)
14. Eisenberg SP, Hale KK, Heimdal P, Thompson RC,. Location of the protease-inhibitory region of secretory leukocyte protease inhibitor. J Biol Chem 1990; 265: 7976-7981.
15. Zhang Y, DeWitt DL, McNeely TB, Wahl SM, Wahl LM,. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases. J Clin Invest 1997; 99: 894-900. (Pubitemid 27123626)
16. McNeely TB, Dealy M, Dripps DJ, Orenstein JM, Eisenberg SP, Wahl SM,. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J Clin Invest 1995; 96: 456-464.
17. Ma G, Greenwell-Wild T, Lei K, Jin W, Swisher J, Hardegen N, Wild CT, Wahl SM,. Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection. J Exp Med 2004; 200: 1337-1346. (Pubitemid 39552574)
18. Jin FY, Nathan C, Radzioch D, Ding A,. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 1997; 88: 417-426. (Pubitemid 27131383)
19. Devoogdt N, Revets H, Kindt A, Liu YQ, De Baetselier P, Ghassabeh GH,. The tumor-promoting effect of TNF-alpha involves the induction of secretory leukocyte protease inhibitor. J Immunol 2006; 177: 8046-8052. (Pubitemid 44846322)
20. Taggart CC, Cryan SA, Weldon S, Gibbons A, Greene CM, Kelly E, Low TB, O'Neill SJ, McElvaney NG,. Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding. J Exp Med 2005; 202: 1659-1668. (Pubitemid 41815872)
21. Yan C, Grimm WA, Garner WL, Qin L, Travis T, Tan N, Han YP,. Epithelial to mesenchymal transition in human skin wound healing is induced by tumor necrosis factor-{alpha} through bone morphogenic protein-2. Am J Pathol 2010; 176: 2247-2258.
22. Meyer-Hoffert U,. Neutrophil-derived serine proteases modulate innate immune responses. Front Biosci 2009; 14: 3409-3418.
23. Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, Carter HL, Chen WJ, Clay WC, Didsbury JR, Hassler D, Hoffman CR, Kost TA, Lambert MH, Leesnitzer MA, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, Su JL, Warner J, Willard D, Becherer JD,. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 1997; 385: 733-736. (Pubitemid 27098095)
24. Han YP, Tuan TL, Hughes M, Wu H, Garner WL,. Transforming growth factor-beta-and tumor necrosis factor-alpha-mediated induction and proteolytic activation of MMP-9 in human skin. J Biol Chem 2001; 276: 22341-22350.
25. Buck M, Houglum K, Chojkier M,. Tumor necrosis factor-alpha inhibits collagen alpha1(I) gene expression and wound healing in a murine model of cachexia. Am J Pathol 1996; 149: 195-204. (Pubitemid 26230991)
26. Daley JM, Brancato SK, Thomay AA, Reichner JS, Albina JE,. The phenotype of murine wound macrophages. J Leukoc Biol 2010; 87: 59-67.
27. Ashcroft GS, Mills SJ,. Androgen receptor-mediated inhibition of cutaneous wound healing. J Clin Invest 2002; 110: 615-624. (Pubitemid 34988785)
28. Price NM, Gilman RH, Uddin J, Recavarren S, Friedland JS,. Unopposed matrix metalloproteinase-9 expression in human tuberculous granuloma and the role of TNF-alpha-dependent monocyte networks. J Immunol 2003; 171: 5579-5586. (Pubitemid 37432849)
29. Wysocki AB, Staiano-Coico L, Grinnell F,. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 1993; 101: 64-68. (Pubitemid 23213014)
30. Bullen EC, Longaker MT, Updike DL, Benton R, Ladin D, Hou Z, Howard EW,. Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol 1995; 104: 236-240.
31. Verrecchia F, Mauviel A,. TGF-beta and TNF-alpha: antagonistic cytokines controlling type I collagen gene expression. Cell Signal 2004; 16: 873-880. (Pubitemid 38638777)
32. Sano C, Shimizu T, Tomioka H,. Effects of secretory leukocyte protease inhibitor on the tumor necrosis factor-alpha production and NF-kappaB activation of lipopolysaccharide-stimulated macrophages. Cytokine 2003; 21: 38-42. (Pubitemid 36369375)
33. True AL, Rahman A, Malik AB,. Activation of NF-kappaB induced by H(2)O(2) and TNF-alpha and its effects on ICAM-1 expression in endothelial cells. Am J Physiol Lung Cell Mol Physiol 2000; 279: L302-311.
34. Martinez FO, Helming L, Gordon S,. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009; 27: 451-483.
35. Wynn TA, Barron L,. Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis 2010; 30: 245-257.
36. Heinrich SA, Messingham KA, Gregory MS, Colantoni A, Ferreira AM, Dipietro LA, Kovacs EJ,. Elevated monocyte chemoattractant protein-1 levels following thermal injury precede monocyte recruitment to the wound site and are controlled, in part, by tumor necrosis factor-alpha. Wound Rep Regen 2003; 11: 110-119. (Pubitemid 36514822)
37. Maish GO 3rd, Shumate ML, Ehrlich HP, Cooney RN,. Tumor necrosis factor binding protein improves incisional wound healing in sepsis. J Surg Res 1998; 78: 108-117. (Pubitemid 28419220)
38. Mori R, Kondo T, Ohshima T, Ishida Y, Mukaida N,. Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration. FASEB J 2002; 16: 963-974. (Pubitemid 34753502)
39. Streit M, Beleznay Z, Braathen LR,. Topical application of the tumour necrosis factor-alpha antibody infliximab improves healing of chronic wounds. Int Wound J 2006; 3: 171-179.
40. Hirano Y, Kojima T, Kanayama Y, Shioura T, Hayashi M, Kida D, Kaneko A, Eto Y, Ishiguro N,. Influences of anti-tumour necrosis factor agents on postoperative recovery in patients with rheumatoid arthritis. Clin Rheumatol 2010; 29: 495-500.